gene therapy product (TKT)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegene therapy product (TKT)
Drug Alias Namegene therapy (Transkaryotic Therapies)gene therapy (Transkaryotic Therapies)hemophilia A gene therapy (Transkaryotic Therapies)antihemophilic globulin gene therapy (Transkaryotic Therapies)gene therapy (Transkaryotic Therapies)
ClassificationBiologics
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWestern Europe
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth BioPharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Human Genetic Therapies, IncWyeth BioPharma
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A